Wednesday, 24 May 2017

Australia News

  • Phylogica assess financial, strategic opportunities

    Australia |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Phylogica has engaged Griffin Securities, a specialty investment bank located in New York City, to conduct a formal process for evaluating strategic opportunities available to th...Read more

  • Soon, a single flu shot may offer universal immunity!

    Australia |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: A single vaccine that immunizes against all types of influenza may soon be a reality, after a team of scientists from Australia and China have discovered how the body's immunity ...Read more

  • Sale of wound care devices spurs in Asia-Pacific: Frost & Sullivan analysis report

    Australia |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Advanced wound care and modern wound closure products are gaining an edge over traditional wound dressings in Asia Pacific as lower bed capacity in hospitals and the trend toward...Read more

  • TGA approves Hospira's biosimilar Inflectra

    Australia |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: US drug giant Hospira recently announced that the biosimilar Inflectra (infliximab) has been registered as a therapy in Australia. Inflectra is an artificial compound that is bio...Read more

  • Sun Pharma to buy GSK's Opiates business in Australia

    Australia |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: GlaxoSmithKline (GSK) and Sun Pharmaceutical announced that their respective wholly owned subsidiaries have reached an agreement related to GSK's Opiates business in Australia. ...Read more

  • Novogen's drug shows positive result for brain cancer

    Australia |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Australian biotechnology company, Novogen's lead candidate product, TRXE-009, has shown a positive result in treating adult and pediatric brain cancer. The study looked at the a...Read more

  • Amneal pharma to acquire Actavis Australia's generic business

    Australia |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: US-based Amneal pharmaceuticals announced the acquisition of Actavis pharmaceuticals' generic business in Australia. The company has inked a binding letter of intent to acquire t...Read more

  • ANI pharma, IDT Australia to commercialize US generic drugs

    Australia |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: ANI Pharmaceuticals, a global specialty pharmaceutical company recently announced collaboration with IDT Australia a global generic manufacturer, to commercialize up to 18 previo...Read more

  • Novartis to acquire Spinifex Pharmaceuticals

    Australia |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Novartis has announced that it has entered into an agreement to acquire Spinifex Pharmaceuticals, a US and Australia-based, privately held development stage company, focused on d...Read more

  • Charting Success year-on-year

    Australia |  Analysis | By BioSpectrum Bureau | 0 Comment

    Singapore:  CSL, AustraliaChairman: Professor John ShineRevenue: $6407.8 mnBusiness: Developer and manufacturer of vaccines and plasma protein biotherapies Starting the year on a positiv...Read more

  • Phosphagenics achieves biggest milestone yet

    Australia |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Australian drug delivery technology company, Phosphagenics has achieved succes in its multi-dose oxymorphone patch phase I trial in 12 subjects. The phase I trial was conducted a...Read more

  • Market cap in APAC touches $200 bn

    Australia |  Analysis | By Narayan Kulkarni | 0 Comment

    About 500 bioscience companies comprising pharmaceutical, biotechnology and medical technology companies listed on different stock exchanges in Asia Pacific (APAC) region and in American st...Read more

  • Aussie firm trials combination therapy for melanoma

    Australia |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Australia based Viralytics has initiated a clinical trial to assess its oncolytic virus, Cavatak, in combination with the checkpoint inhibitor Keytruda (pembrolizumab) in late-st...Read more

  • Aussie chemotherapy drug gets orphan designation

    Australia |  News | By BioSpectrum Bureau | 0 Comment

    Singappore: US Food and Drug Administration (FDA) has granted orphan drug designation to chemotherapy drug candidate Cantrixil for ovarian cancer developed by CanTx, a subsidiary joint vent...Read more

  • Scientists find microRNA linked to prostate cancer

    Australia |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: 'Non-coding' genes known as microRNAs play a big role in cancer through their mechanical regulation of other genes. In a three-year study, researchers at Garvan Institute of Medi...Read more

  • Prana completes phase II trial with PBT2

    Australia |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Prana Biotechnology announced the successful completion of Reach2HD, a phase II clinical trial in patients with early to mid-stage Huntington disease. The company expects to anno...Read more

  • Research at Peter Mac proves Cylene drug's efficacy

    Australia |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Cylene Pharmaceuticals' research collaborators at the Peter MacCallum Cancer Centre (Peter Mac) in Melbourne, Australia, have established, for the first time, that RNA Polymerase...Read more

  • Indian researcher named Woman of the Year in NSW

    Australia |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Dr Minoti Apte, a 56-year-old pancreatic researcher from India, has been named as the New South Wales 'Woman of the Year' 2015 for her excellent contributions to medical research...Read more

Survey Box

Will biobanking change healthcare in the world?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls